Sanofi’s $17bn sale of Opella to US investors advances following ...
8 hours ago · Sanofi has placed an enterprise value of €16m ($17m) on Opella, around 14 times the estimated core earnings (EBITDA) for 2024, as per a 21 October press release.
Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake …
8 hours ago · Sanofi SNY has entered into exclusive negotiations with U.S.-based private equity company Clayton Dubilier & Rice (CD&R) for the potential sale of a 50% controlling stake in its consumer ...
Press Release: Sanofi and CD&R partner to fuel Opella’s …
18 hours ago · Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare. Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder ; With 11,000 talented and passionate people bringing iconic brands to life, Opella poised to ignite new bold development journey
Sanofi reaches deal on terms of sale of consumer health arm, say …
1 day ago · PARIS (Reuters) -Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R), French ...
Sanofi in exclusive talks with CD&R over sale of $17 bln Opella
18 hours ago · French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R).
Press Release: Sanofi in discussions to sell a controlling stake in Opella
Paris, October 11, 2024. Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of a 50% controlling stake in Opella, its consumer healthcare business. Should these discussions lead to a positive outcome, any agreement would be subject to …
Sanofi in talks to sell 50% stake in consumer health business to …
Oct 11, 2024 · Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, the French pharmaceutical group said on...
Sanofi Enters Exclusive Talks With CD&R for Opella Sale - U.S. News
17 hours ago · The French pharmceutical company said its Opella business has been valued at around 16 billion euros ($17.38 billion), or 14 times EBITDA in 2024, and French public investment bank Bpifrance is ...
Sanofi in 'exclusive negotiations' to sell 50% stake in €16B …
8 hours ago · Opella, which counts 11,000 employees in 100 countries, generated sales of 5.2 billion euros ($5.6 billion) in 2023, accounting for 11% of Sanofi’s revenue. Opella operates 13 manufacturing ...
Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI | Reuters
1 day ago · The plan for Public Investment Bank (BPI) to take a 1% stake in Opella, for about 150 million euros ($162.98 million), came through a tri-party agreement between Sanofi, the French state and CD&R ...